Search research articles
Contact Us
Filters
Showing results (21-30 of 50) with videos related to
Page
of 5
Sort By:
Critical Care Medicine
|
February 1, 1982
Selective chemical hepatic sympathectomy in the dog
F D Allman, E L Rogers, D A Caniano, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 21, 2000
Functional consequences of the developmental arrest and follicular exclusion of anti-double-stranded DNA B cells
L Mandik-Nayak, S j Seo, A Eaton-Bassiri, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 24, 2001
A common pathway for dendritic cell and early B cell development
D Izon, K Rudd, W DeMuth, et al.
Blood
|
June 15, 1996
BCL-6 expression during B-cell activation
D Allman, A Jain, A Dent, et al.
Current Topics in Microbiology and Immunology
|
January 1, 1995
Rapid identification of novel human lymphoid-restricted genes by automated DNA sequencing of subtracted cDNA libraries
L M Staudt, A Dent, C Ma, et al.
The Oncologist
|
June 14, 2023
Activity of Tivozanib in Non-clear Cell Renal Cell Carcinoma: Subgroup Analysis From a Phase II Randomized Discontinuation Trial
Pedro C Barata, Alexander Chehrazi-Raffle, Kimberly D Allman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 1998
A Phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumors
J Cassidy, L Dirix, D Bissett, et al.
HIV/AIDS Policy & Law Review
|
March 21, 2009
U.N. guidance note on HIV and sex work "reworked" by activists
M Seshu, A Hunter, E Hunter, et al.
Science (New York, N.Y.)
|
July 3, 1999
Positive selection of natural autoreactive B cells
K Hayakawa, M Asano, S A Shinton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 1998
Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer
M Mackean, A Planting, C Twelves, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 50) with videos related to
Sort By:
Page
of 5
Critical Care Medicine
|
February 1, 1982
Selective chemical hepatic sympathectomy in the dog
F D Allman, E L Rogers, D A Caniano, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 21, 2000
Functional consequences of the developmental arrest and follicular exclusion of anti-double-stranded DNA B cells
L Mandik-Nayak, S j Seo, A Eaton-Bassiri, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 24, 2001
A common pathway for dendritic cell and early B cell development
D Izon, K Rudd, W DeMuth, et al.
Blood
|
June 15, 1996
BCL-6 expression during B-cell activation
D Allman, A Jain, A Dent, et al.
Current Topics in Microbiology and Immunology
|
January 1, 1995
Rapid identification of novel human lymphoid-restricted genes by automated DNA sequencing of subtracted cDNA libraries
L M Staudt, A Dent, C Ma, et al.
The Oncologist
|
June 14, 2023
Activity of Tivozanib in Non-clear Cell Renal Cell Carcinoma: Subgroup Analysis From a Phase II Randomized Discontinuation Trial
Pedro C Barata, Alexander Chehrazi-Raffle, Kimberly D Allman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 1998
A Phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumors
J Cassidy, L Dirix, D Bissett, et al.
HIV/AIDS Policy & Law Review
|
March 21, 2009
U.N. guidance note on HIV and sex work "reworked" by activists
M Seshu, A Hunter, E Hunter, et al.
Science (New York, N.Y.)
|
July 3, 1999
Positive selection of natural autoreactive B cells
K Hayakawa, M Asano, S A Shinton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 1998
Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer
M Mackean, A Planting, C Twelves, et al.
Page
of 5